|
|
(10 intermediate revisions not shown) |
Line 8: |
Line 8: |
| <script type="text/javascript" src="http://users.skumleren.net/gumle/lightbox/js/lightbox.js"></script> | | <script type="text/javascript" src="http://users.skumleren.net/gumle/lightbox/js/lightbox.js"></script> |
| <link rel="stylesheet" href="http://users.skumleren.net/gumle/lightbox/css/lightbox.css" type="text/css" media="screen" /> | | <link rel="stylesheet" href="http://users.skumleren.net/gumle/lightbox/css/lightbox.css" type="text/css" media="screen" /> |
| + | <script type="text/javascript" src="http://users.skumleren.net/gumle/lightbox/lightboxSEB.js"></script> |
| | | |
| <script type="text/javascript" src="http://ajax.googleapis.com/ajax/libs/jquery/1.4.2/jquery.min.js" charset="utf-8"></script> | | <script type="text/javascript" src="http://ajax.googleapis.com/ajax/libs/jquery/1.4.2/jquery.min.js" charset="utf-8"></script> |
Line 139: |
Line 140: |
| | | |
| <br><br> | | <br><br> |
- | A guide for the most common design requests is given below. The guide is based on work conducted by Morten H. H. Nørholm and Hansen et. al. | + | A guide for the most common design requests is given below. The guide is based on work conducted by Morten H. H. Nørholm and Hansen et. al. Figures obtained from Genee et al. (in preparation). |
| </p> | | </p> |
| | | |
Line 162: |
Line 163: |
| | | |
| | | |
- | <a href="https://static.igem.org/mediawiki/2011/f/f8/Koncept_igem_forside_1.png" rel="lightbox[gallery]" title=""> | + | <a href="https://static.igem.org/mediawiki/igem.org/7/79/Mathilde.png" rel="lightbox" title=""> |
- | <img src="https://static.igem.org/mediawiki/2011/thumb/f/f8/Koncept_igem_forside_1.png/800px-Koncept_igem_forside_1.png" alt="" height="200px" /> | + | <img src="https://static.igem.org/mediawiki/igem.org/7/79/Mathilde.png" alt="" height="200px" /> |
| </a> | | </a> |
| | | |
Line 184: |
Line 185: |
| | | |
| <p align="center"> | | <p align="center"> |
- | <img src="https://static.igem.org/mediawiki/2011/6/6d/Customization_seemless_assembly.png" height="200px" > </img> | + | |
| + | <a href="https://static.igem.org/mediawiki/igem.org/7/79/Mathilde.png" rel="lightbox" title=""> |
| + | <img src="https://static.igem.org/mediawiki/igem.org/7/79/Mathilde.png" alt="" height="200px" /> |
| + | </a> |
| </p> | | </p> |
| <br> | | <br> |
Line 205: |
Line 209: |
| <dd>4. To amplify the BioBricks the protocol <a href="https://2011.igem.org/Team:DTU-Denmark-2/Team/Protocols#PCR">Amplification of biobricks by PCR</a> can be used. </dd> | | <dd>4. To amplify the BioBricks the protocol <a href="https://2011.igem.org/Team:DTU-Denmark-2/Team/Protocols#PCR">Amplification of biobricks by PCR</a> can be used. </dd> |
| <dd>5. Check the PCR reaction on an agarose gel before assembly. The new BioBricks can be used directly or purified by agarose-gel purification if needed. </dd> | | <dd>5. Check the PCR reaction on an agarose gel before assembly. The new BioBricks can be used directly or purified by agarose-gel purification if needed. </dd> |
- | <dd>6. The assembly of new BioBricks parts is performed according to the protocol <a href="https://2011.igem.org/Team:DTU-Denmark-2/Team/Protocols#USER cloning">USER cloning</a>. </dd> | + | <dd>6. The assembly of new BioBricks should be performed according to the protocol <a href="https://2011.igem.org/Team:DTU-Denmark-2/Team/Protocols#USER cloning">USER cloning</a>. </dd> |
| <dd>7. A BioBrick, device or plasmid with the desired point mutation should now have been assembled.</dd> | | <dd>7. A BioBrick, device or plasmid with the desired point mutation should now have been assembled.</dd> |
| </dt> | | </dt> |
Line 211: |
Line 215: |
| <br> | | <br> |
| <p align="center"> | | <p align="center"> |
- | <img src="https://static.igem.org/mediawiki/2011/b/b9/Customization_point-mutation_not_degenerate.png" height="200px" > </img> | + | |
| + | <a href="https://static.igem.org/mediawiki/igem.org/7/79/Mathilde.png" rel="lightbox" title=""> |
| + | <img src="https://static.igem.org/mediawiki/igem.org/7/79/Mathilde.png" alt="" height="200px" /> |
| + | </a> |
| </p> | | </p> |
| | | |
Line 220: |
Line 227: |
| | | |
| <p align="center"> | | <p align="center"> |
- | <img src="https://static.igem.org/mediawiki/2011/f/fc/Customization_point-mutation_degenerate.png" height="200px" > </img> | + | |
| + | <a href="https://static.igem.org/mediawiki/igem.org/7/79/Mathilde.png" rel="lightbox" title=""> |
| + | <img src="https://static.igem.org/mediawiki/igem.org/7/79/Mathilde.png" alt="" height="200px" /> |
| + | |
| + | </a> |
| </p> | | </p> |
| | | |
Line 231: |
Line 242: |
| <a name="Deletions"></a><h2><b>Deletions</b></h2> | | <a name="Deletions"></a><h2><b>Deletions</b></h2> |
| <p align="justify"> | | <p align="justify"> |
- | In some cases whole deletion in parts of a gene or a whole gene can be of interest. This can be the case for creating new BioBricks or if a plasmid contains undesired parts.<br><br>
| + | With this guide a gene or part of a gene or any other desired sequence of a plasmid, device, or BioBrick can be deleted. <br><br> |
| <dt> | | <dt> |
- | <dd>1. First the deletion site is defined.</dd> | + | <dd>1. First the site of the deletion should be defined.</dd> |
- | <dd>2. The primers need to be designed so the fusion point will bridge two desired sections of the gene at the matching USER linkers.</dd> | + | <dd>2. The primers need to be designed so that the fusion point will bridge two desired sections of the gene at the matching USER linkers.</dd> |
- | <dd>3. The primers are ordered from your favourite company. Notice that the price and delivery time can be increased, when ordering primers with a uracil incorporated. DTU-Denmark-2 has had great experience with primers from Integrated DNA Technology.</dd> | + | <dd>3. The primers are ordered from your favourite company. Notice that the price can be a bit higher and delivery time a bit longer, when ordering primers with a uracil incorporated. We have had a good experience with the price, delivery time and quality of the primers ordered from Integrated DNA Technology.</dd> |
- | <dd>4. To amplify the BioBricks the protocol <a href="https://2011.igem.org/Team:DTU-Denmark-2/Team/Protocols#PCR">Amplification of biobricks by PCR</a> is used. </dd> | + | <dd>4. To amplify the BioBricks the protocol <a href="https://2011.igem.org/Team:DTU-Denmark-2/Team/Protocols#PCR">Amplification of biobricks by PCR</a> can be used. </dd> |
- | <dd>5. Check the PCR reaction on an agarosegel before assembly. The new BioBricks can be used directly or purified by agarose-gel purification if needed. </dd> | + | <dd>5. Check the PCR reaction on an agarose gel before assembly. The new BioBricks can be used directly or purified by agarose-gel purification if needed. </dd> |
- | <dd>6. The assembly of new BioBricks parts are performed according to the protocol <a href="https://2011.igem.org/Team:DTU-Denmark-2/Team/Protocols#USER cloning">USER cloning</a>. </dd> | + | <dd>6. The assembly of new BioBricks should be performed according to the protocol <a href="https://2011.igem.org/Team:DTU-Denmark-2/Team/Protocols#USER cloning">USER cloning</a>. </dd> |
- | <dd>7. A BioBrick, device or new plasmid with the deletion has been assembled.</p></dd> | + | <dd>7. A BioBrick, device or new plasmid with the deletion should now have been assembled.</p></dd> |
| </dt> | | </dt> |
| | | |
| | | |
| <p align="center"> | | <p align="center"> |
- | <img src="https://static.igem.org/mediawiki/2011/e/ee/Customization_deletion.png" height="200px" > </img> | + | |
| + | |
| + | |
| + | <a href="https://static.igem.org/mediawiki/igem.org/7/79/Mathilde.png" rel="lightbox" title=""> |
| + | <img src="https://static.igem.org/mediawiki/igem.org/7/79/Mathilde.png" alt="" height="200px" /> |
| + | |
| + | </a> |
| + | |
| </p> | | </p> |
| | | |
Line 252: |
Line 270: |
| <a name="Adding short sequences"></a><h2><b>Adding short sequences</b></h2> | | <a name="Adding short sequences"></a><h2><b>Adding short sequences</b></h2> |
| <p align="justify"> | | <p align="justify"> |
- | Introducing a short sequence can be of interest if two proteins is desired to be close to each other by a linker. This can increase speed of one or more coupled enzymatic reactions. The linker can as a single point mutation be degenerated or not, which means only one or both primers needs to carry the mutation. | + | Short sequences such as ribosomal binding sites, kozak sequences etc. can be added by incorporating them into the primer that will be used to amplify the part it should be fused with. |
- | When creating a linker a short sequence of either random or known sequence is added by incorporating the sequence into the forward or reverse primer. For both typer of linker the below process in creating the assembled plasmid is overall the same.</p><br> | + | Introducing a short sequence can also be of interest when two proteins are wished to be connected by a linker. The linker can also carry a single point mutation, be degenerate or non-degenerate, which means that only one or both primers needs to carry the mutation. |
| + | When creating a linker a short sequence of either random or known sequence is added by incorporating the sequence into the forward or reverse primers.</p><br> |
| | | |
| <b>Introducing a linker</b><br> | | <b>Introducing a linker</b><br> |
| <p align="justify"> | | <p align="justify"> |
| <dt> | | <dt> |
- | <dd>1. When introducing a linker in the connection of a gene of interest (GOI), the first step is to define the mutation.</dt> | + | <dd>1. When introducing a linker in the connection with a gene of interest (GOI), the first step is to define the mutation.</dt> |
- | <dd>2. Primers are designed for the defined mutation site. To introduce the desired mutation one nucleotide are changed. Four primers are used per mutation.</dt> | + | <dd>2. Primers are designed for the defined mutation site. To introduce the desired mutation one nucleotide should be changed in the primer. Four primers are used per mutation.</dt> |
- | <dd>3. The primers are ordered from your favourite company. Notice that the price and delivery time can be increased, when ordering primers with a uracil incorporated. DTU-Denmark-2 has had great experience with primers from Integrated DNA Technology.</dt> | + | <dd>3. The primers are ordered from your favourite company. Notice that the price can be a bit higher and delivery time a bit longer, when ordering primers with a uracil incorporated. We have had a good experience with the price, delivery time and quality of the primers ordered from Integrated DNA Technology.</dt> |
- | <dd>4. To amplify the BioBricks the protocol <a href="https://2011.igem.org/Team:DTU-Denmark-2/Team/Protocols#PCR">Amplification of biobricks by PCR</a> is used. </dt> | + | <dd>4. To amplify the BioBricks the protocol <a href="https://2011.igem.org/Team:DTU-Denmark-2/Team/Protocols#PCR">Amplification of biobricks by PCR</a> can be used. </dt> |
- | <dd>5. Check the PCR reaction on an agarosegel before assembly. The new BioBricks can be used directly or purified by agarose-gel purification if needed. </dt> | + | <dd>5. Check the PCR reaction on an agarose gel before assembly. The new BioBricks can be used directly or purified by agarose-gel purification if needed. </dt> |
- | <dd>6. The assembly of new BioBricks parts are performed according to the protocol <a href="https://2011.igem.org/Team:DTU-Denmark-2/Team/Protocols#USER cloning">USER cloning</a>. </dt> | + | <dd>6. The assembly of new BioBricks and parts should be performed according to the protocol <a href="https://2011.igem.org/Team:DTU-Denmark-2/Team/Protocols#USER cloning">USER cloning</a>. </dt> |
- | <dd>7. A BioBrick with a mutation in GOI has been assembled.</p></dt>
| + | |
| </dt> | | </dt> |
| <p align="justify"> | | <p align="justify"> |
- | The figure below shows the process of creating a degenerated linker (illustrated with a loop). Primers can be designed by using the standard Plug’n’Play linkers.</p> <br> | + | The figure below shows the process of creating a degenerate linker (illustrated with a loop). Primers can be designed by using the standard Plug’n’Play linkers.</p> <br> |
| <p align="center"> | | <p align="center"> |
- | <img src="https://static.igem.org/mediawiki/2011/2/2f/Customization_linker_not_degenerate_2.png" height="200px" > </img> | + | |
| + | |
| + | <a href="https://static.igem.org/mediawiki/igem.org/7/79/Mathilde.png" rel="lightbox" title=""> |
| + | <img src="https://static.igem.org/mediawiki/igem.org/7/79/Mathilde.png" alt="" height="200px" /> |
| + | </a> |
| + | |
| + | |
| </p> | | </p> |
| <br><br> | | <br><br> |
- | Illustrated below the process of creating a not degenerated linker.<br><br> | + | Illustrated below the process of creating a non-degenerate linker.<br><br> |
| <p align="center"> | | <p align="center"> |
- | <img src="https://static.igem.org/mediawiki/2011/a/a3/Customization_linker_degenerate.png" height="200px" > </img> | + | |
| + | <a href="https://static.igem.org/mediawiki/igem.org/7/79/Mathilde.png" rel="lightbox" title=""> |
| + | <img src="https://static.igem.org/mediawiki/igem.org/7/79/Mathilde.png" alt="" height="200px" /> |
| + | </a> |
| + | |
| </p> | | </p> |
| | | |
Line 281: |
Line 309: |
| <a name="Example"></a><h2><b>Example</b></h2> | | <a name="Example"></a><h2><b>Example</b></h2> |
| <p align="justify"> | | <p align="justify"> |
- | Synthetic biology is all about creativity, and sometimes the standard is just not enough making it necessary to combine the above mentioned customizations. The figure below illustrates that "Plug 'n' Play with DNA" makes it possible to assemble a degenerate linker (red), a non-degenerate linker (yellow), introduce a non-degenerate point mutation (X) as well as a degenerate point mutation(N) into one plasmid in just ONE round of cloning. </p> <br> | + | Synthetic biology is all about creativity, and sometimes the standard is just not enough, making it necessary to combine the above mentioned customizations. The figure below illustrates that "Plug 'n' Play with DNA" makes it possible to assemble a degenerate linker (red), a non-degenerate linker (yellow), introduce a non-degenerate point mutation (X) as well as a degenerate point mutation (N) into one plasmid in just ONE round of cloning. </p> <br> |
| | | |
| <p align="center"> | | <p align="center"> |
- | <img src="https://static.igem.org/mediawiki/2011/9/9d/Customization_combination.png" height="200px" > </img> | + | <a href="https://static.igem.org/mediawiki/igem.org/7/79/Mathilde.png" rel="lightbox" title=""> |
| + | <img src="https://static.igem.org/mediawiki/igem.org/7/79/Mathilde.png" alt="" height="200px" /> |
| + | </a> |
| + | |
| </p> | | </p> |
| | | |
Line 318: |
Line 349: |
| <a name="Tips & Tricks"></a><h2><b>Tips & Tricks</b></h2> | | <a name="Tips & Tricks"></a><h2><b>Tips & Tricks</b></h2> |
| <dd> | | <dd> |
- | <li> Design primers so their mutual Tm's are within 2-5°C.</li> | + | <li> Design primers så the Tms between forward and reverse primer are within 2-5°C.</li> |
- | <li> Remember that the annealing temperature should normally be 3°C under the Tm. However, when the USER extension is add on the primer and the Tm is increased. We have experience that the best results are obtain when the final annealing temperature is above 62°C, if the primer was around the 59°C to begin with.</li> | + | <li> Remember that the annealing temperature should normally be 3°C under the Tm. However, when the linker is added to the primer, the Tm is increased. We have experienced that the best results are obtain when the final annealing temperature is above 62°C, if the primer have a Tm around 59°C to begin with.</li> |
| <li> The X7 Phusion polymerase have in the PCR reaction a extension time of 1000bp per minut.</li> | | <li> The X7 Phusion polymerase have in the PCR reaction a extension time of 1000bp per minut.</li> |
| </dd> | | </dd> |
Line 326: |
Line 357: |
| <a name="References"></a><h2><b>References</b></h2> | | <a name="References"></a><h2><b>References</b></h2> |
| | | |
- | [1]Nørholm, M.H.H. A mutant Pfu DNA polymerase designed for advanced uracil-excision DNA engineering. BMC Biotechnol. 10, 21, 2010.<br><br> | + | [1] Nørholm, M.H.H. A mutant Pfu DNA polymerase designed for advanced uracil-excision DNA engineering. BMC Biotechnol. 10, 21, 2010.<br><br> |
| | | |
- | [2]Hansen, B. G.; Salomonsen, B.; Nielsen, M. T.; Nielsen, J. B.; Hansen, N. B.; Nielsen, K.F.; Regueira, T. B.; Nielsen, J.; Patil, K. R.; Mortensen, U. H.; “Versatile enzyme expression and Characterization system for Aspergillus, with the Penicillium brevicompactum Polyketide Synthase Gene from the Mycophenolic Acid Gene Cluster as a Test Case.” American Society for Microbiology, 2011, 3044-3051.<br><br> | + | [2] Hansen, B. G.; Salomonsen, B.; Nielsen, M. T.; Nielsen, J. B.; Hansen, N. B.; Nielsen, K.F.; Regueira, T. B.; Nielsen, J.; Patil, K. R.; Mortensen, U. H.; “Versatile enzyme expression and Characterization system for Aspergillus, with the Penicillium brevicompactum Polyketide Synthase Gene from the Mycophenolic Acid Gene Cluster as a Test Case.” American Society for Microbiology, 2011, 3044-3051.<br><br> |
| + | |
| + | [3] Genee HJ, Bonde MT, Bagger FO, Olsen LR. PHUSER v2 (In preparation). |
| + | <br><br> |
| | | |
| | | |